Jessica S. Brosnahan

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

Sélidji Todagbé Agnandji, Angela Huttner, Madeleine E. Zinser et al. · New England Journal of Medicine · 2015 · 413 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV

Anne Rechtien, Laura Richert, Hadrien Lorenzo et al. · Cell Reports · 2017 · 125 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study

Angela Huttner, Sélidji Todagbé Agnandji, Christophe Combescure et al. · The Lancet Infectious Diseases · 2018 · 82 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization

Christine Dahlke, Rahel Kasonta, Sebastian Lunemann et al. · EBioMedicine · 2017 · 78 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial

Sélidji Todagbé Agnandji, José F. Fernandes, Emmanuel B. Bache et al. · PLoS Medicine · 2017 · 68 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17